{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.11.1527",
  "meta": {
    "versionId": "16",
    "lastUpdated": "2021-02-20T01:03:49.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1527",
  "version": "20210220",
  "name": "Scopolamine",
  "status": "active",
  "date": "2021-02-20T01:03:49-05:00",
  "publisher": "NCQA PHEMUR",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "concept": [
          {
            "code": "1046787",
            "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
          },
          {
            "code": "1046815",
            "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
          },
          {
            "code": "1046997",
            "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
          },
          {
            "code": "1048124",
            "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
          },
          {
            "code": "1048147",
            "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.3111 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
          },
          {
            "code": "198207",
            "display": "scopolamine 0.4 MG/ML Injectable Solution"
          },
          {
            "code": "226552",
            "display": "72 HR scopolamine 0.0139 MG/HR Transdermal System"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:d34fcc78-efc4-469b-bb7a-0c850b01dfff",
    "timestamp": "2022-09-28T01:13:45-04:00",
    "total": 6,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1046787",
        "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1046815",
        "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1046997",
        "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1048124",
        "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "198207",
        "display": "scopolamine 0.4 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "226552",
        "display": "72 HR scopolamine 0.0139 MG/HR Transdermal System"
      }
    ]
  }
}